50
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Biopsy Pathology Predicts Patients with Ulcerative Colitis Subsequently Requiring Surgery

Pages 200-205 | Published online: 08 Jul 2009

  • Langholz E, Munkhol m P, Davidsen M, Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994;107:3-11.
  • Triantafillidis JK, Emmanouilidis A, Manousos O, Pomonis E, Tsitsa C, Cheracakis P, et al. Ulcerative colitis in Greece: clinicoepidemiologica 1 data, course, and prognostic factors in 413 consecutive patients. J Clin Gastroenterol 1998;27:204-10.
  • Fanner RG, Easley KA, Rankin GB. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term followup of 1116 patients. Dig Dis Sei 1993;38:1137-46.
  • Chakravarty BJ. Predictors and the rate of medical treatment failure in ulcerative colitis. Am J Gastroenterol 1993;88:852-5.
  • Trudove SC, Willoughby CP, Lee EG, Kettlewell MGW. Further experience in the treatment of severe attacks of ulcerative colitis. Lancet 1978;2:1086-8.
  • Travis SPL, Farrant JM, Ricketts C, Nolan DJ, Mortensen NM, Kettlewell MGW, et al. Predicting outcome in severe ulcerative colitis. Gut 1996:38:905-10.
  • Ritchie JK. Ileostomy and excisional surgery for chronic inflammatory disease of the colon: a survey of one hospital region. Gut 1971:12:528-40.
  • Becker JM. Deal pouch-anal anastomosis: current status and controversies. Surgery 1993:113:599-602.
  • Pemberton JH, Kelly KA, Beart RW Jr, Dozois RR, Wolff BG, Ilstrup DM. Deal pouch-anal anastomosis for chronic ulcerative colitis: long-term results. Ann Surg 1987:206:504-13.
  • Schoetz DJ Jr, Coller JA. Veidenheimer MC. Ileoanal reservoir for ulcerative colitis and familial polyposis. Arch Surg 1986; 121:404-9.
  • Lindgren SC, Flood LM, Kilander AF, Löfberg R, Persson TB, Sjödahl RI. Early predictors of glucocorticosteroi d treatment failure in severe and moderately severe attacks of ulcerative colitis. Eur J Gastroenterol Hepatol 1998; 10:831 -5.
  • Hearing SD, Norman M, Probert CSJ, Haslam N, Dayan CM. Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes. Gut 1999:45:382-8.
  • Shinozaki M, Suzuki K, Sawada T, Tsuno N, Higuchi Y, Muto T. Steroid complications and surgery in intractable ulcerative colitis. J Gastroenterol 1998;33:1%-200.
  • Facldis K, Plevy SE, Vasiliauskas EA, Kam L, Taylor K, Targan ST, et al. Crohn's disease-associated genetic marker is seen in medically unresponsive ulcerative colitis patients and may be associated with pouch-specific complications. Dis Colon Rectum 1999:42:601 -6.
  • Shimada T, Hiwatashi N, Yamazaki H, Kinouchi Y, Yoyota T. Relationship between glucocorticoid receptor and response to glucocorticoid therapy in ulcerative colitis. Dis Colon Rectum 1997;40 Suppl:S54-8.
  • Maikowitz J, Kahn E, Grancher K, Hyams J, Treem W, Daum F. Atypical rectosigmoid histology in children with newly diagnosed ulcerative colitis. Am J Gastroenterol 1993;88:2034-7.
  • Oshitani N, Campbell A, Kitano A, Kobayashi K, Jewell DP. In situ comparison of phenotypical and functional activity of infiltrating cells in ulcerative colitis mucosa. J Palhol 1996; 178:95 -9.
  • Heatley RV, James PD. Eosinophils in the rectal mucosa. A simple method of predicting the outcome of ulcerative proctocolitis? Gut 1978:20:787-91.
  • Choy MY, Walker-Smith JA, Williams CB, MacDonald TT. Activated eosinophils in chronic inflammatory bowel disease. Lancet 1990;336:126-7.
  • Willoughby CP, Pins J, Truelove SC. Tissue eosinophils in ulcerative colitis. Scand J Gastroenterol 1979;14:395-9.
  • Sarin SK, Malhotra V, Gupta SS, Karol A, Gaur SK, Anand BS. Significance of eosinophil and mast cell counts in rectal mucosa in ulcerative colitis. A prospective controlled study. Dig Dis Sei 1987:32:363-7.
  • Binder V. The content of eosinophil granulocytes in the colonie mucosa in ulcerative colitis. Scand J Gastroenterol 1970;5:70712.
  • Tanaka M, Riddell RH, Saito H, Soma Y, Hidaka H, Kudo H. Morphologic criteria applicabl e to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis. Scand J Gastroenterol 1999;34:55-67.
  • Tanaka M, Saito H, Fukuda S, Sasaki Y, Munakata A, Kudo H. Simple mucosal biopsy criteria differentiating among Crohn's disease, ulcerative colitis, and other forms of colitis: measurement of validity. Scand J Gastroenterol 2000;35:281 -6.
  • Shivananda S, Hordijk ML, Ten Kate M, Probert CSJ, Mayberry JF. Differential diagnosis of inflammatory bowel disease. A comparison of various diagnostic classifications. Scand J Gastroenterol 1991:26:167-73.
  • Lennard-Jones M. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989;24 Suppl 170:2-6.
  • Bischoff SC, Wedemeyer J, Herrmann A, Meier PN, Trautwein C, Cetin Y, et al. Quantitative assessment of intestinal eosinophil s and mast cells in inflammatory bowel disease. Histopathol ogy 1996:28:1-13.
  • D'Haens G, Geboes K, Peelers M, Baert F, Ectors N, Rutgeerts P. Patchy cecal inflammation associated with distal ulcerative colitis: a prospective endoscopie study. Am J Gastroenterol 1997:92:1275-9.
  • Binder V, Eisborg L, Grabe J, Hendriksen C, Høj L, Jensen KB, et al. Disodium cromoglycate in the treatment of ulcerative colitis and Crohn's disease. Gut 1981:22:55-60.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.